Interactions between cytokines and cytotoxic drugs: putative molecular mechanisms in experimental hematology and oncology.
Kreuser
E D
ED
Department of Hematology and Oncology, Klinikum Steglitz, Free University of Berlin, Germany.
Wadler
S
S
Thiel
E
E
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology / Q000627:therapeutic use*; D016207:Cytokines / Q000494:pharmacology / Q000627:therapeutic use*; D004347:Drug Interactions; D004351:Drug Resistance; D004790:Enzyme Induction / Q000187:drug effects; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007372:Interferons / Q000494:pharmacology; D007378:Interleukins / Q000494:pharmacology; D007938:Leukemia / Q000628:therapy; D012334:RNA, Neoplasm / Q000096:biosynthesis; D013940:Thymidylate Synthase / Q000096:biosynthesis; D059004:Topoisomerase I Inhibitors; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
D016207:Cytokines; D007378:Interleukins; D012334:RNA, Neoplasm; D059004:Topoisomerase I Inhibitors; D014409:Tumor Necrosis Factor-alpha; D016179:Granulocyte Colony-Stimulating Factor; D007372:Interferons; D013940:Thymidylate Synthase